Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on September 2, 2026

Sep. 2, 2026

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

Indeterminate GlobeNewswire

Sep. 2, 2026

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

Indeterminate GlobeNewswire

Sep. 2, 2026

Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company

Indeterminate GlobeNewswire

Sep. 2, 2026

Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential

Indeterminate GlobeNewswire

Sep. 2, 2026

Charles IT Expands AI and Automation Capabilities Through Acquisition of Descent

Indeterminate GlobeNewswire

Sep. 2, 2026

VEON to Release 3Q26 Earnings on November 6, 2026, Capital Markets Day Scheduled for November 16, 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

Cardiff Oncology to Participate in September 2026 Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

FactSet Schedules Fourth Quarter 2026 Earnings Call

Indeterminate GlobeNewswire

Sep. 2, 2026

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Aeluma to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 16, 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Maze Therapeutics to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Climb Bio to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)

Indeterminate GlobeNewswire

Sep. 2, 2026

European Wax Center Releases Limited Edition Golden Orchard Body Butter and Body Polish for Post-Wax Skincare

Indeterminate GlobeNewswire

Sep. 2, 2026

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Verano Announces Upcoming Conference Participation

Indeterminate GlobeNewswire

Sep. 2, 2026

Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

GXO Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire